Back
W.W. Grainger Vs. Kymera Therapeutics Industry Stock Comparison
Buy
60
GWW
W.W. Grainger
Last Price:
977.56
Seasonality Move:
4.3%
Buy
58
KYMR
Kymera Therapeutics
Last Price:
46.87
Seasonality Move:
25.63%
Buy
60
W.W. Grainger (GWW)
is a Buy
Is W.W. Grainger a Buy, Sell or Hold?
- The current W.W. Grainger [GWW] share price is $972.14. The Score for GWW is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- GWW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.19. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GWW Stock Price Chart
What is W.W. Grainger's stock price today?
-
The W.W. Grainger share price today is $972.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GWW is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
GWW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.21 | Buy |
| Relative Strength Index (14 RSI): | 54.12 | Buy |
| Chaikin Money Flow: | 130803 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (952.07 - 975.71) | Buy |
| Bollinger Bands (100): | (914.09 - 966.43) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.16 | Buy |
| Relative Strength Index (14 RSI): | 53.14 | Buy |
| Chaikin Money Flow: | -53339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.25 - 48.01) | Buy |
| Bollinger Bands (100): | (32.65 - 44.29) | Buy |
GWW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 961.53 | Buy |
| 20-day SMA: | 964.59 | Buy |
| 50-day SMA: | 951.35 | Buy |
| 200-day SMA: | 923.6 | Buy |
| 8-day EMA: | 960.64 | Buy |
| 20-day EMA: | 962.04 | Buy |
| 50-day EMA: | 954.43 | Buy |
| 200-day EMA: | 906.15 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.97 | Sell |
| 20-day SMA: | 46.18 | Buy |
| 50-day SMA: | 42.65 | Buy |
| 200-day SMA: | 35.44 | Buy |
| 8-day EMA: | 46.57 | Sell |
| 20-day EMA: | 45.95 | Buy |
| 50-day EMA: | 43.11 | Buy |
| 200-day EMA: | 36.01 | Buy |
W.W. Grainger Earnings Growth & GWW Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, an increase next quarter of $0.94 per share, an increase this year of $2.38 per share, and an increase next year of $3.54 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
W.W. Grainger Technical Analysis
| Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||